Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Antibiotics in Measles Infection
NCT00168532Phase 3Completed
- Sponsor
- Bandim Health Project
- Start
- Jan 1998
- Primary completion
- Oct 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of trimethoprim + sulfamethoxazole in measles (2 arms), sponsored by Bandim Health Project. Primary endpoints: Incidence of post-measles pneumonia and Admission to hospital. Started Jan 1998; status: completed.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
measles
Beyond the preview
Go deeper on NCT00168532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168532.